Key result
Ewing-like sarcomas emerge as a heterogeneous family of round cell sarcomas lacking EWSR1-ETS fusions.
Why the study?
Ewing-like sarcomas are a heterogeneous group lacking the pathognomonic molecular hallmark of Ewing sarcoma, with unclear optimal therapeutic approaches.
Ewing-like sarcomas represent distinct entities with unique molecular characteristics rather than simply a subgroup of Ewing sarcoma, necessitating further collaborative efforts to determine optimal therapeutic approaches.
Answers are grounded in this paper and cite their sources.
Distinguishes these sarcomas diagnostically from Ewing; leaves open optimal therapies pending collaborative trials.
Ewing-like sarcomas are an emerging subgroup of small round blue cell sarcomas that share various degrees of morphological, immunohistochemical, molecular, and clinical similarity with Ewing sarcoma. Despite these similarities, Ewing-like sarcomas lack the pathognomonic molecular hallmark of Ewing sarcoma: A translocation between a gene of the RNA-binding TET family (EWSR1 or FUS) with a gene of the ETS-transcription family ( FLI1, ERG, ETV1, ETV4, or FEV). Recently, increased use of modern molecular methods based on next-generation sequencing have enabled the identification of distinct subgroups within this previously uncharacterized group of Ewing-like sarcomas based on the discovery of novel molecular driving events. The focus of this review is to provide an update on the main subcategories of Ewing-like sarcomas discovered to date: CIC-rearranged sarcomas, BCOR-rearranged sarcomas, sarcomas with a rearrangement between EWSR1 and a non-ETS family gene, and the substantial fraction of tumors which remain uncharacterized by molecular methods. There is increasing evidence that these tumors represent stand-alone entities with unique characteristics rather than simply a subgroup of Ewing sarcoma; thus, the question of the best therapeutic approach for these often aggressive sarcomas remains of primary importance. Ultimately, large collaborative efforts will be necessary to better determine the characteristics of this rare, heterogeneous family of tumors.
No takes yet. Share an insight, caveat, or question.
Renzi et al. (2018) conducted a review in Ewing-like sarcomas. Ewing-like sarcomas are an emerging, heterogeneous family of round cell sarcomas with distinct molecular subgroups, such as CIC-rearranged and BCOR-rearranged sarcomas, lacking EWSR1-ETS fusions.
Synapse has enriched 10 related papers. Consider them for comparative context: